BioSpace News Archive

Pharmaceutical Care Management Association President and CEO JC Scott issued the following statement on the Administration’s proposed Medicare Part B pricing model

Janssen Announcement Validates AMPEL’s Ranking of Stelara

Elpis Biomed Ltd. (Elpis), a University of Cambridge spin-out developing high quality human cells via its proprietary OPTi-OX platform, is pleased to announce that life science entrepreneur Dr Jonathan Milner, Deputy Chairman and Founder of Abcam, mentioned the company

Consolidated Results of Operations, As Reported and As Adjusted - Three-month periods ended September 30, 2018 and 2017:

Dr. Borgen will interview prominent figures in the breast cancer community.

Trethera Corporation and KYAN Therapeutics announced an agreement to collaborate on preclinical studies evaluating up to four different tumor types beginning this year leveraging their unique expertise to develop best-in-class combination therapies addressing unmet needs in solid tumors.

The Institute for Alternative Futures (IAF) and The Kresge Foundation release a new publication, Human Services and Human Progress 2035, that explores what human progress, human need and human services will be in the United States in 2035.

Dr. Malcolm Pike and Marvin Scott Also to Be Honored; Q&A with Dr. Eric Manheimer, the Inspiration Behind NBC Series New Amsterdam

Shionogi & Co., Ltd. announced today that The Lancet Infectious Diseases journal has published clinical results from the pivotal randomized controlled trial evaluating cefiderocol for the treatment of complicated urinary tract infection (cUTI) in patients at risk of multidrug-resistant Gram-negative infections.

Following the recent full legalisation of cannabis in Canada, European-based market intelligence and strategic consultancy firm, Prohibition Partners, have released the most comprehensive report into the Oceania region´s legal cannabis industry - The Oceania Cannabis Report™.